These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22167048)

  • 1. First human face transplantation: 5 years outcomes.
    Petruzzo P; Testelin S; Kanitakis J; Badet L; Lengelé B; Girbon JP; Parmentier H; Malcus C; Morelon E; Devauchelle B; Dubernard JM
    Transplantation; 2012 Jan; 93(2):236-40. PubMed ID: 22167048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Registry on Hand and Composite Tissue allotransplantation.
    Petruzzo P; Dubernard JM
    Clin Transpl; 2011; ():247-53. PubMed ID: 22755418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Findings of Chronic Rejection in a Face Grafted Patient.
    Petruzzo P; Kanitakis J; Testelin S; Pialat JB; Buron F; Badet L; Thaunat O; Devauchelle B; Morelon E
    Transplantation; 2015 Dec; 99(12):2644-50. PubMed ID: 25989498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder.
    Barth RN; Nam AJ; Stanwix MG; Kukuruga D; Drachenberg CI; Bluebond-Langner R; Hui-Chou H; Shipley ST; Bartlett ST; Rodriguez ED
    Transplantation; 2009 Dec; 88(11):1242-50. PubMed ID: 19996923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes 18 months after the first human partial face transplantation.
    Dubernard JM; Lengelé B; Morelon E; Testelin S; Badet L; Moure C; Beziat JL; Dakpé S; Kanitakis J; D'Hauthuille C; El Jaafari A; Petruzzo P; Lefrancois N; Taha F; Sirigu A; Di Marco G; Carmi E; Bachmann D; Cremades S; Giraux P; Burloux G; Hequet O; Parquet N; Francès C; Michallet M; Martin X; Devauchelle B
    N Engl J Med; 2007 Dec; 357(24):2451-60. PubMed ID: 18077810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human facial allotransplantation: a 2-year follow-up study.
    Guo S; Han Y; Zhang X; Lu B; Yi C; Zhang H; Ma X; Wang D; Yang L; Fan X; Liu Y; Lu K; Li H
    Lancet; 2008 Aug; 372(9639):631-8. PubMed ID: 18722867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus in kidney transplantation from marginal donors.
    Pisani F; Buonomo O; Iaria G; Iorio B; Rizzello A; Pollicita S; De Luca L; Valeri M; Boffo V; Famulari A; Casciani CU
    Transplant Proc; 2004 Apr; 36(3):495-6. PubMed ID: 15110569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pediatric renal transplantation: clinical analysis of 23 cases].
    Chen JH; Shen W; He Q; Jiang R; Peng WH
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1100-3. PubMed ID: 15498295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facial transplantation.
    Shanmugarajah K; Hettiaratchy S; Butler PE
    Curr Opin Otolaryngol Head Neck Surg; 2012 Aug; 20(4):291-7. PubMed ID: 22894997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Innsbruck hand transplant program: update at 8 years after the first transplant.
    Brandacher G; Ninkovic M; Piza-Katzer H; Gabl M; Hussl H; Rieger M; Schocke M; Egger K; Loescher W; Zelger B; Ninkovic M; Bonatti H; Boesmueller C; Mark W; Margreiter R; Schneeberger S
    Transplant Proc; 2009 Mar; 41(2):491-4. PubMed ID: 19328910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
    Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
    Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
    Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
    Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease--a common and serious complication after intestinal transplantation.
    Herlenius G; Fägerlind M; Krantz M; Mölne J; Olausson M; Gäbel M; Friman V; Oltean M; Friman S
    Transplantation; 2008 Jul; 86(1):108-13. PubMed ID: 18622286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.